Oklo CEO associated entities sell 200K shares
Oklo Inc. director and Co-Founder/CEO Jacob DeWitte reported open‑market sales of Class A Common Stock by entities associated with him and his spouse.
Rhea-AI Filing Summary
Oklo Inc. director and Co-Founder/CEO Jacob DeWitte reported open‑market sales of Class A Common Stock by entities associated with him and his spouse. On July 1, 2026, a total of 200,000 shares were sold in four transactions at reported weighted average prices between about $51.52 and $54.30, including 40,000 shares at $53.28, 60,000 at $52.30, 40,000 at $53.71, and 60,000 at $52.80. The filing notes these sales were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025. After these transactions, various indirect holdings show balances such as 569,479 shares held by a Caroline Cochran GRAT and 511,533 shares held directly by DeWitte, alongside multi‑million‑share family trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 60,000 | $52.80 | $3.17M |
| Sale | Class A Common Stock | 40,000 | $53.71 | $2.15M |
| Sale | Class A Common Stock | 60,000 | $52.30 | $3.14M |
| Sale | Class A Common Stock | 40,000 | $53.28 | $2.13M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (9)
- F1. The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.51- $53.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.49- $54.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.52- $52.51 inclusive. The Reporting Person's spouse undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F6. For more information about the equity of the Issuer held by the Reporting Person's spouse, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F7. Represents securities held by the Reporting Person's spouse.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.08- $53.49 inclusive. The Reporting Person's spouse undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F9. Represents securities beneficially owned by the Reporting Person's spouse.
Key Figures
Key Terms
Rule 10b5-1 plan financial
weighted average price financial
GRAT financial
beneficially owned financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Oklo (OKLO) report in this Form 4?
Were the Oklo (OKLO) insider sales made under a Rule 10b5-1 plan?
What do the weighted average price footnotes mean in the Oklo (OKLO) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.